Procter & Gamble (PG) came out with quarterly earnings of $1.54 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $1.52 per share a year ago.
Shares of Procter & Gamble (PG) dipped in premarket trading Thursday after the consumer goods giant's fiscal third-quarter sales came in below analysts' estimates and it cut its full-year outlook.
Procter & Gamble's quarterly earnings topped estimates, but its revenue fell short of expectations. The company also cut its forecast for its full-year core earnings per share and revenue.
Procter & Gamble (PG 2.55%) sells household essentials that people need even in times of economic hardship.
Beyond analysts' top -and-bottom-line estimates for P&G (PG), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended March 2025.
Recently, Zacks.com users have been paying close attention to P&G (PG). This makes it worthwhile to examine what the stock has in store.
P&G (PG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
PG's Q3 results are expected to reflect strong organic sales growth, driven by steady demand for daily-use products and its focus on a strong brand portfolio.
Procter & Gamble, Merck, Medtronic, Johnson & Johnson, Intuit, and Comcast have lagged behind the market's rebound, but they look set to rise from here.
PG's global reach and brand strength support long-term growth, but valuation, China headwinds and macro risks warrant a cautious, hold-worthy outlook.
Zacks.com users have recently been watching P&G (PG) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
First, Jim Cramer said the market selloff was an opportunity. Then, he said the Trump Administration had made a horrible mistake by rushing to create a tariff system that would hit dozens of nations.